Purpose. The aim of this study was to develop a multiplex PCR (mPCR) for simultaneous detection (single reaction) of six clinically relevant streptococcal species: Streptococcus pneumoniae, Streptococcus suis, Streptococcus gallolyticus subsp. gallolyticus, S. gallolyticus subsp. pasteurianus, Streptococcus intermedius and Streptococcus anginosus/constellatus.
INTRODUCTION
Streptococci are part of the normal flora and are pathogenic in humans and animals. They possess variable pathogenic potential, being responsible for meningitis, pneumonia, endocarditis, arthritis, abscesses and septicaemia. For diagnostic purposes, it is important to differentiate Streptococcus pneumoniae from other viridans group streptococci (a, g or small-zone b-haemolytic) [1] . Identification of Streptococcus suis is also important since it is a zoonotic pathogen that causes invasive infections in humans: such infections have received increasing attention worldwide [2] . Phenotypically, S. suis resembles the viridans streptococcal species Streptococcus gordonii, Streptococcus sanguinis and Streptococcus parasanguinis, and may therefore be misidentified in many human diagnostic laboratories [3] .
The Streptoccus bovis/Streptococcus equinus complex (SBSEC) comprises a variety of species and subspecies including Streptococcus gallolyticus subsp. gallolyticus (S. bovis biotype I), S. gallolyticus subsp. pasteurianus (S. bovis biotype II/2), S. gallolyticus subsp. macedonicus, Streptococcus infantarius subsp. infantarius (S. bovis biotype II/1), S. infantarius subsp. coli (S. bovis biotype II/1), S. bovis, S. equinus and Streptococcus alactolyticus [4, 5] . Of these, S. gallolyticus is considered an emerging cause of infectious endocarditis, bacteraemia and meningitis in humans, and cases have been reported in the USA, Scotland, Spain, Australia, Japan, Korea and Thailand [6] . Misidentification has been reported due to the biochemical diversity of SBSEC members [7] .
The Streptococcus anginosus group is considered a part of the viridans group of streptococci and is composed of three distinct species: S. anginosus (comprises subsp. anginosus and subsp. whileyi), Streptococcus intermedius and Streptococcus constellatus (comprises subsp. pharyngis, subsp. constellatus and subsp. viborgensis) [8, 9] . The S. anginosus group has been associated with multiple types of infections such as pharyngitis, bacteraemia, endocarditis, and soft tissue infections of the neck, brain, lungs and liver [9] . In addition, S. anginosus was reported to be more likely to be involved in polymicrobial infections while S. intermedius was more commonly associated with haematogenous spread and deep-seated infections and S. constellatus was more often associated with superficial infections [10] . Due to the lack of reliable biochemical profile differences, isolates of the S. anginosus group are rarely routinely identified to the species level by conventional biochemical tests in clinical laboratories [8, 9] . However, the S. anginosus group can be identified to the species level by using matrix-assisted laser desorption ionization time-of-flight MS, which provides accurate species-level identification [11] .
Data from the laboratory surveillance system of the National Institute of Health (Thai-NIH), a reference laboratory in Thailand, revealed that S. pneumoniae, S. suis and S. gallolyticus are the most frequent isolates of the non-bhaemolytic streptococcal group sent from many hospitals in Thailand to be confirmed at Thai-NIH (Annual reports, 2011-2015 in Thai language). Non-b-haemolytic and bhaemolytic S. anginosus group members are also frequently sent for confirmation to the Thai-NIH (Annual reports, 2011-2015 in Thai language). Identification of these streptococci using conventional biochemical tests is laborious, time-consuming and expensive (for some reagents), and may lead to misidentification. Commercial identification kits provide an alternative that is quick and easy; however, they are too expensive for many laboratories in developing countries. The need for a rapid, simple and reliable method for the identification of streptococci at the species level may be developed based on molecular methods. Therefore, the PCR method would be an attractive alternative for the identification of streptococci, due to its rapid analytical capacity and low cost. Herein, we describe a multiplex PCR (mPCR) used to identify six medically relevant streptococci, S. suis, S. pneumoniae, S. gallolyticus subsp. gallolyticus, S. gallolyticus subsp. pasteurianus, S. intermedius and S. anginosus/S. constellatus, recovered from various clinical specimens of several diseases for diagnostic, treatment and epidemiological or outbreak investigations.
METHODS

Bacterial strains
Six reference streptococcal species, S. suis CCUG 7984, S. pneumoniae ATCC 33400, S. gallolyticus subsp. gallolyticus ATCC 43143, S. gallolyticus subsp. pasteurianus ATCC 43144, S. intermedius ATCC 27335 and S. anginosus ATCC 33397 (a representative of the S. anginosus group) were used as positive controls for the mPCR in this study. In addition, S. constellatus subsp. pharyngis CCUG 46377 and S. constellatus subsp. constellatus ATCC 27823, members of the S. anginosus group, were also included in this study to evaluate the primers of the S. anginosus group used in the mPCR (Table 1) . Collectively, 442 streptococcal isolates collected from sterile sites in seven tertiary hospitals in northeast Thailand between 2014 and 2015 were used to validate the mPCR (Table 2) .
We also included reference strains of other bacterial species in this study to evaluate possible non-specific reactions. These strains were Streptococcus pyogenes SF370, Streptococcus agalactiae ATCC 13813, Streptococcus dysgalactiae subsp. equisimilis CCUG 36637, S. dysgalactiae subsp. 
Identification
Biochemical tests including API 20 Strep (bioM eriux) and conventional biochemical tests described elsewhere were used to identify the 442 streptococcal isolates collected from seven tertiary hospitals in north-east Thailand [8] .
Multiplex PCR Genomic DNAs were extracted using a QIAamp DNA Mini Kit (Qiagen) according to the manufacturer's instructions. The PCR mixture contained 1Â MyTaq HS Red Mix (Bioline) and 0.2 µM of each primer. A list of the primers used for the streptococcal species included in the mPCR is presented in Table 1 . The following PCR thermal profile was used: initial activation of DNA polymerase at 95 C for 3 min; plus 30 cycles of denaturation at 95 C for 20 s, primer annealing and extension at 62 C for 90 s, and a final extension at 72 C for 5 min.
The PCR products were analysed by gel electrophoresis for 30 min on 2 % agarose gels in 0.5Â TBE buffer. The gels were stained with ethidium bromide and visualized under UV light (GeneGenius Bioimaging System; SynGene). The sizes of the PCR products were determined by comparison with a molecular size standard (GeneRuler 100 bp Plus DNA ladder; Thermo Fisher Scientific).
The limit of detection of the mPCR was then evaluated. Each of the six reference species was diluted using 10-fold serial dilutions from an original concentration of OD 600 of 0.6, which was equivalent to 10 8 c.f.u. ml
À1
. Genomic DNA was prepared from 1 ml of each dilution using the QIAamp DNA Mini Kit (Qiagen). Each dilution was also plated onto sheep blood agar for quantification of colony-forming units to determine the minimum number required for the mPCRs.
RESULTS AND DISCUSSION
We developed this mPCR to identify six medically relevant streptococci, S. suis, S. pneumoniae, S. gallolyticus subsp. gallolyticus, S. gallolyticus subsp. pasteurianus, S. intermedius and S. anginosus/S. constellatus, that are clinically important and have the potential to cause invasive infections and diseases, such as community-acquired pneumonia, meningitis, sepsis, septic-shock-like syndrome, infective endocarditis, gallbladder or liver parenchymal disease, and coincident colorectal carcinoma [12] . Many such invasive infections are of considerable public health concern; for example, pneumococcal disease causes over 800 000 deaths in children (<5 years old) worldwide annually, [12] . Additionally, these streptococci are difficult to identify by using biochemical tests compared to b-haemolytic streptococci such as S. pyogenes or S. agalactiae. The mPCR in this study can provide an alternative identification method for isolated colonies which are suspected to be non-b-haemolytic or small-colony-forming b-haemolytic streptococci (S. anginosus group suspected), recovered from various clinical specimens of several diseases for diagnostic, treatment and epidemiological investigation.
As shown in Fig. 1 , the six streptococcal species were all positive, based on amplification of the 723 bp of recN for ) . The specificity of the mPCR was examined using reference strains of other bacterial species as described in the Methods. Non-specific reactions were not observed with the other bacterial species.
The limit of detection in this assay was 374, 572, 681, 1016, 1140 and 1538 c.f.u. ml À1 for S. pneumoniae, S. suis, S. anginosus, S. intermedius, S. gallolyticus subsp. gallolyticus and S. gallolyticus subsp. pasteurianus, respectively. At least 1.6Â10 3 c.f.u. ml À1 for all bacterial species tested could be detected by this mPCR.
Of the 442 clinical streptococci isolates collected from seven tertiary hospitals in north-east Thailand, this mPCR assay confirmed, in accordance with the biochemical tests, 38 isolates of S. suis, 62 isolates of S. pneumoniae, 45 isolates of S. gallolyticus subsp. pasteurianus, two isolates of S. gallolyticus subsp. gallolyticus, one isolate of S. intermedius and 15 isolates of S. anginosus/S. constellatus (Table 2 ). In addition, the API 20 Strep identified the S. anginosus group as S. anginosus (n=9) and S. constellatus subsp. constellatus (n=6) ( Table 2 ). However, 279 isolates were not detected using this mPCR, in agreement with biochemical identification that revealed S. pyogenes (n=49), S. agalactiae (n=171), S. canis (n=1), S. dysgalactiae subsp. equisimilis (n=17), the S. salivarius group (n=4), the S. mitis group (n=27) and the S. sanguinis group (n=10) ( Table 2 ). This suggests that our mPCR is promising for use regarding the identification of these six medically relevant streptococci.
The fact that S. gallolyticus was the second most common Streptococcus found in this study after S. pneumoniae indicates the importance of this species in human infections in north-east Thailand. S. gallolyticus has also been reported to be predominant in northern Thailand and misidentifications between S. gallolyticus and S. suis have been reported [6] . Since we used a specific primer for S. suis (recN), strains of both subspecies of S. gallolyticus and S. infantarius (SBSEC) gave a negative PCR. This suggests that our mPCR has high specificity towards the bacterial species targeted by the genes and that the PCR conditions are optimal.
As shown in Table 2 , the use of conventional biochemical tests failed to identify some of the streptococci when compared with the API 20 Strep and mPCR. In particular, the conventional biochemical tests could not differentiate between S. suis and the S. sanguinis group nor between the viridans streptococcal species, such as the S. mitis group, S. salivarius group, S. sanguinis group and S. anginosus group. Although the API 20 Strep could identify most streptococci included in this study to the species level, some bacterial species needed additional complementary biochemical tests to confirm them as belonging to the S. anginosus group or S. pneumoniae. For example, for the latter, evaluation of optochin susceptibility and bile solubility was required. Both tests required at least an additional 18-24 h to obtain results, while our mPCR combined the annealing and extension reactions into a single step that can shorten the whole PCR time by about 50 min; therefore, the mPCR process (DNA extraction + mPCR + gel electrophoresis) only needed 3 h and correctly identified these species. Although this mPCR method is less time-consuming, a drawback is that it does not differentiate S. anginosus/S.constellatus at the species level. However, Takao et al. [13] recently reported a PCR to identify species of the S. anginosis group which may be used in association with this mPCR method.
To the best of our knowledge, there is currently no report of an mPCR to detect or identify several species of these clinically relevant streptococci, such as that developed in this study. Most of the described PCRs detect or identify only single species or streptococcal groups: this is the case for S. suis [14, 15] , S. gallolyticus [16] , SBSEC [17, 18] , S. pneumoniae [19, 20] and the S. anginosus group [13, 21] .
The mPCR described herein can be applied to the identification of these six clinically relevant streptococci from pure culture. It was shown to be rapid (3 h for the process overall), simple and reliable for the identification of these six streptococci at the species level (Table 2) . It can be easily used in some tertiary hospitals, university hospitals and reference laboratories where rapid diagnostic or epidemiological investigation is required. However, an improved mPCR should be developed to cover other clinically important streptococcal species, such as S. dysgalactiae, S. pseudopneumoniae, S. infantarius (SBSEC) and viridans streptococci (e.g. S. mitis, S. salivarius, S. gordonii, S. sanguinis and S. oralis), as well as to differentiate between S. constellatus (three subspecies) and S. anginosus in the S. anginosus group. Although a limitation of our mPCR is that it was developed to be used with pure cultures, an extension of this protocol for direct use with specimens would be very useful if developed and validated in the near future.
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